FDA takes first step in possible reversal of ban on some peptides The Washington Post The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few RFK Jr., MAHA push for fewer peptide restrictions